Clinical Response of Rifaximin Treatment in Patients with Abdominal Bloating.

CONCLUSIONS: Despite the limitations of this retrospective study, our data confirms that rifaximin may be beneficial for abdominal bloating. Further prospective clinical trial with a larger cohort is needed.
PMID: 30270593 [PubMed - in process]

Source: Korean J Gastroenter... - September 25, 2018 Category: Gastroenterology Authors: Yoon K, Kim N, Lee JY, Oh DH, Seo AY, Yun CY, Yoon H, Shin CM, Park YS, Lee DH Tags: Korean J Gastroenterol Source Type: research